Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Exp Med. Dec 20, 2024; 14(4): 94845
Published online Dec 20, 2024. doi: 10.5493/wjem.v14.i4.94845
Published online Dec 20, 2024. doi: 10.5493/wjem.v14.i4.94845
Comprehensive analysis of the impact of primary percutaneous coronary intervention on patients with ST-segment elevation myocardial infarction
Ayrton I Bangolo, Nikita Wadhwani, Department of Internal Medicine, Palisades Medical Center, North Bergen, NJ 07047, United States
Author contributions: Bangolo AI and Wadhwani N contributed significantly to the conception of this scholarly work, interpretation of data, drafting of initial manuscript, and submission of its revised version.
Conflict-of-interest statement: All authors have no conflicts of interest to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ayrton I Bangolo, MBBS, MD, Doctor, Department of Internal Medicine, Palisades Medical Center, 7600 River Road, North Bergen, NJ 07047, United States. ayrtonbangolo@yahoo.com
Received: March 26, 2024
Revised: September 14, 2024
Accepted: September 30, 2024
Published online: December 20, 2024
Processing time: 218 Days and 19.9 Hours
Revised: September 14, 2024
Accepted: September 30, 2024
Published online: December 20, 2024
Processing time: 218 Days and 19.9 Hours
Core Tip
Core Tip: This study by Saeed and Faeq reveals the significant impact of timely primary percutaneous coronary intervention on mortality reduction in ST-segment elevation myocardial infarction patients. The analysis showed that chronic kidney disease, specific culprit coronary lesions, and an atypical presentation characterized by presence of either syncope, cardiogenic shock, or ventricular arrhythmias on arrival were predictive of post-percutaneous coronary intervention mortality.